Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
One of the most prevalent dermatological conditions in children is alopecia areata (AA), which is caused by an autoimmune attack on the hair follicles that is mediated by T cells. Youngsters and their ...
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...
Small areas of scarring alopecia gradually appear and may become ... as relapse is common once treatment is stopped. Addition of topical mupirocin can help to improve outcome.
Treatment with etrasimod in the ELEVATE UC ... eosinophilic oesophagitis, alopecia areata and atopic dermatitis, which if positive could dramatically increase the drug's potential.